Abstract

The mitochondrial transcription factor A (TFAM) is considered a key factor in mitochondrial DNA (mtDNA) copy number. Given that the regulation of active copies of mtDNA is still not fully understood, we investigated the effects of CRISPR-Cas9 gene editing of TFAM in human embryonic kidney (HEK) 293T cells on mtDNA copy number. The aim of this study was to generate a new in vitro model by CRISPR-Cas9 system by editing the TFAM locus in HEK293T cells. Among the resulting single-cell clones, seven had high mutation rates (67–96%) and showed a decrease in mtDNA copy number compared to control. Cell staining with Mitotracker Red showed a reduction in fluorescence in the edited cells compared to the non-edited cells. Our findings suggest that the mtDNA copy number is directly related to TFAM control and its disruption results in interference with mitochondrial stability and maintenance.

Highlights

  • TFAM is a key mitochondrial modulator with a proposed role in mitochondrial DNA transcription and replication, and is required to regulate mtDNA copy numbers [1,2]

  • Both gRNAs resulted in genome editing of the first exon of TFAM

  • Given the important role of mitochondria in cellular homeostasis, dysfunction of this organelle can lead to several common diseases [23]

Read more

Summary

Introduction

TFAM is a key mitochondrial modulator with a proposed role in mitochondrial DNA (mtDNA) transcription and replication, and is required to regulate mtDNA copy numbers [1,2]. TFAM is an abundant protein, present in approximately 1000 molecules per mtDNA molecule in mammalian cells, which is enough to coat the entire mitochondrial genome [3]. It has been shown that TFAM is directly involved in mitochondrial genome repair by modulating the access of repair proteins to mtDNA [4,5]. Alterations in mtDNA, such as a decrease in quantity, can cause impaired energy production leading to several clinical disorders. The result of this dysfunction can cause damage to mtDNA compromising mitochondrial function [6,7].

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.